ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 223 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,180 | -98.3% | 276 | -98.4% | 0.00% | -100.0% |
| Q4 2022 | $525,952 | -52.6% | 17,132 | -47.2% | 0.00% | -33.3% |
| Q3 2022 | $1,109,000 | -2.9% | 32,432 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $1,142,000 | +82.4% | 32,932 | +131.4% | 0.00% | +200.0% |
| Q1 2022 | $626,000 | -24.7% | 14,232 | +7.6% | 0.00% | -50.0% |
| Q4 2021 | $831,000 | -39.9% | 13,227 | +0.8% | 0.00% | -33.3% |
| Q3 2021 | $1,383,000 | -35.0% | 13,127 | +9.1% | 0.00% | -40.0% |
| Q2 2021 | $2,129,000 | +37.3% | 12,027 | +3.4% | 0.01% | +66.7% |
| Q1 2021 | $1,551,000 | +3.1% | 11,627 | +4.6% | 0.00% | 0.0% |
| Q4 2020 | $1,505,000 | +41.4% | 11,119 | -13.1% | 0.00% | 0.0% |
| Q3 2020 | $1,064,000 | -26.3% | 12,793 | -27.2% | 0.00% | -25.0% |
| Q2 2020 | $1,444,000 | +78.9% | 17,581 | +12.1% | 0.00% | +33.3% |
| Q1 2020 | $807,000 | – | 15,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |